TOP Web Exclusives

Of the 24 patients receiving sotatercept monotherapy, 20 had primary myelofibrosis. Their median baseline hemoglobin level was 7.5 g/dL.

This week Sellas Life Sciences Group announced data from a study of NeuVax (nelipepimut-S) in combination with Herceptin (trastuzumab) in patients with HER2 1+/2+ breast cancer.
There were a number of areas where we asked the forecast panelists questions specifically regarding oncology, and how the changing environment might relate to oncology pharmacists.
The National Prescription Drug Take-Back addresses a vital public safety and public health issue. Many patients are not aware that the medicines in their cabinets are highly susceptible to diversion, misuse, and abuse.
Adherence to certain strategies can aid pharmacists in successful navigation of our increasingly collaborative healthcare landscape.
At the National Comprehensive Cancer Network 20th Annual Conference, Mario E. Lacouture, MD, presented some clinical pearls that can guide the management of dermatologic toxicities.
Page 3 of 3
Results 21 - 26 of 26